<?xml version="1.0" encoding="windows-1252"?><rss version="2.0" xml:base="http://www.VoxEU.org" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">  <channel>  <atom:link href="http://www.voxeu.org/rss.php?q=node/6728" rel="self" type="application/rss+xml" />  <title>VoxEU.org: Nebibe Varol</title>  <link>http://www.VoxEU.org</link>  <description>Recent Nebibe Varol articles on VoxEU.org</description>  <language>en</language>  <item>    <title>Does price regulation affect the adoption of new pharmaceuticals?</title>    <link>http://www.VoxEU.org/index.php?q=node/6731</link>    <description><![CDATA[<b>Joan Costa-i-Font</b>, <b>Alistair McGuire</b>, <b>Nebibe Varol</b>, 8 July 2011<BR><BR>Pharmaceutical price regulations make drugs more accessible to consumers – if the products are brought to market. This column explores how price regulation affects the diffusion of pharmaceutical treatments. It finds that more regulated, lower-price markets experience the longest delays in launching new medications.<BR><BR>Full Article: <a href='http://www.VoxEU.org/index.php?q=node/6731'>Does price regulation affect the adoption of new pharmaceuticals?</a>]]></description>    <pubDate>Fri, 08 Jul 2011 00:00:00 GMT</pubDate>    <guid isPermaLink="true">http://www.VoxEU.org/index.php?q=node/6731</guid>  </item>  </channel></rss>